Clinical Trial Update: Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating a neoadjuvant combination of darolutamide and relugolix before radical prostatectomy in prostate cancer. Recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)
• ORGOVYX (RELUGOLIX)

Snippet

Sponsor: AdventHealth | Conditions: Prostate CA, Prostate Cancer (Adenocarcinoma) | Phase 1 | Status: RECRUITING